Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Theravance Bio Ord
(NQ:
TBPH
)
9.290
-0.310 (-3.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theravance Bio Ord
< Previous
1
2
3
4
5
Next >
35 Stocks Moving In Monday's Mid-Day Session
January 03, 2022
Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...
Via
Benzinga
To sell or not to sell?
December 14, 2021
Pfizer says its covid pill is 90% effective. PFE got higher target prices from Berenburg and Mizuho
Via
Talk Markets
Wednesday Global Investing Report
December 08, 2021
Between the Amazon Cloud issues and the clouds gathering over the Ukraine border, it's getting harder to tell exactly what's happening to markets. Here are some insights into the international...
Via
Talk Markets
Expert Ratings For Theravance Biopharma
November 05, 2021
Within the last quarter, Theravance Biopharma (NASDAQ:TBPH) has observed t...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 08, 2021
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's...
Via
Benzinga
Thursday Markets Overview
December 02, 2021
Today we are seeing an across-the-board rise in stock prices on hopes for lower inflation and Omicron jabbing.
Via
Talk Markets
Happy December
December 01, 2021
Inflation levels this year will almost certainly lower growth in 2022 because of inflation this year in everything from house prices....to stock prices.
Via
Talk Markets
Theravance Biopharma Pulls Plug On Izencitinib Crohn's Disease Trial
November 16, 2021
Theravance Biopharma Inc (NASDAQ: TBPH) has voluntarily discontinued its Phase 2 study of izencitinib (gut-selective oral pan-JAK inhibitor) in Crohn’s...
Via
Benzinga
Veteran's Day
November 11, 2021
Stock markets took a tumble today across the board, but not as far down as at the opening.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
November 05, 2021
Upgrades For IGM Biosciences Inc (NASDAQ:
Via
Benzinga
A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Jobs Report
November 05, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous session. Investors are awaiting...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 04, 2021
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...
Via
Benzinga
Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript
November 04, 2021
TBPH earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
More Chinese Trouble
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
China's Rescue Of Evergrand
September 23, 2021
The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging.
Via
Talk Markets
Earnings Scheduled For November 3, 2021
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
Analyst Ratings For Theravance Biopharma
September 16, 2021
Analysts have provided the following ratings for Theravance Biopharma (NASDAQ:T...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
September 16, 2021
Barclays boosted Adobe Inc. (NASDAQ:ADBE) price t...
Via
Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
53 Biggest Movers From Yesterday
September 16, 2021
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Theravance Biopharma Stock Dived 16% Today
September 15, 2021
The biotech is not enjoying a winning streak with its pipeline drugs.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...
Via
Benzinga
Why Are Theravance Bio Shares Plummeting Premarket Today?
September 15, 2021
Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 15, 2021
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 27, 2021
Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows. Significant Points: Campbell Soup (NYSE:CPB) was the biggest company by market cap to set a new 52-week low....
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.